Gene · 50848
Papers3,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact. | Cancers (Basel) | 2022 | 36230619 | PubTator, text mining | PubMed |
| Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition. | Front Mol Biosci | 2022 | 36225252 | PubTator, text mining | PubMed |
| Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways. | Mol Cancer | 2022 | 36221123 | PubTator, text mining | PubMed |
| The role of the gut microbiota in health and cardiovascular diseases. | Mol Biomed | 2022 | 36219347 | PubTator, text mining | PubMed |
| Oncolytic Viruses in the Therapy of Lymphoproliferative Diseases. | Mol Biol | 2022 | 36217339 | PubTator, text mining | PubMed |
| Effects of choline containing phospholipids on the neurovascular unit: A review. | Front Cell Neurosci | 2022 | 36212684 | PubTator, text mining | PubMed |
| Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms. | Front Immunol | 2022 | 36211444 | PubTator, text mining | PubMed |
| Identification of core genes and pathways between geriatric multimorbidity and renal insufficiency: potential therapeutic agents discovered using bioinformatics analysis. | BMC Med Genomics | 2022 | 36209090 | PubTator, text mining | PubMed |
| The use of adenoviral vectors in gene therapy and vaccine approaches. | Genet Mol Biol | 2022 | 36206378 | PubTator, text mining | PubMed |
| An overview on the RSV-mediated mechanisms in the onset of non-allergic asthma. | Front Pediatr | 2022 | 36204661 | PubTator, text mining | PubMed |
| Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality. | Front Microbiol | 2022 | 36204626 | PubTator, text mining | PubMed |
| Potential role of extracellular granzyme B in wet age-related macular degeneration and fuchs endothelial corneal dystrophy. | Front Pharmacol | 2022 | 36204224 | PubTator, text mining | PubMed |
| V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy. | Front Immunol | 2022 | 36189222 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection and diabetes: Pathophysiological mechanism of multi-system organ failure. | World J Virol | 2022 | 36188734 | PubTator, text mining | PubMed |
| Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond. | Front Pharmacol | 2022 | 36188615 | PubTator, text mining | PubMed |
| Lupus nephritis: The regulatory interplay between epigenetic and MicroRNAs. | Front Physiol | 2022 | 36187762 | PubTator, text mining | PubMed |
| Loss of contact inhibition of locomotion in the absence of JAM-A promotes entotic cell engulfment. | iScience | 2022 | 36185363 | PubTator, text mining | PubMed |
| Ensembles of endothelial and mural cells promote angiogenesis in prenatal human brain. | Cell | 2022 | 36179668 | PubTator, text mining | PubMed |
| Par3 promotes breast cancer invasion and migration through pull tension and protein nanoparticle-induced osmotic pressure. | Biomed Pharmacother | 2022 | 36179489 | PubTator, text mining | PubMed |
| Nanotechnology for research and treatment of the intestine. | J Nanobiotechnology | 2022 | 36175955 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50848/papers?page=37